Cargando…

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors

INTRODUCTION: Elderly glioblastoma (GBM) patients is characterized by high incidence and poor prognosis. Currently, however, there is still a lack of adequate molecular characterization of elderly GBM patients. The fifth edition of the WHO Classification of Central Nervous System Tumors (WHO5) gives...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yaning, Li, Junlin, Cao, Yaning, Chen, Wenlin, Xing, Hao, Guo, Xiaopeng, Shi, Yixin, Wang, Yuekun, Liang, Tingyu, Ye, Liguo, Liu, Delin, Yang, Tianrui, Wang, Yu, Ma, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288210/ https://www.ncbi.nlm.nih.gov/pubmed/37360159 http://dx.doi.org/10.3389/fnins.2023.1165823

Ejemplares similares

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
por: Ye, Liguo, et al.
Publicado: (2023)

Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients
por: Wang, Zihao, et al.
Publicado: (2021)

Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022
por: Xiao, Zhiyuan, et al.
Publicado: (2022)

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021)

Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials
por: Chen, Wenlin, et al.
Publicado: (2021)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period
por: Wang, Yaning, et al.
Publicado: (2021)

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
por: Zhao, Binghao, et al.
Publicado: (2023)

Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation
por: Liu, Delin, et al.
Publicado: (2022)

Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies
por: Yang, Tianrui, et al.
Publicado: (2022)

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis
por: Zhao, Binghao, et al.
Publicado: (2021)

Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
por: Zhao, Binghao, et al.
Publicado: (2020)

A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study
por: Wang, Zihao, et al.
Publicado: (2020)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
por: Zhao, Binghao, et al.
Publicado: (2022)

Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications
por: Wang, Yaning, et al.
Publicado: (2020)

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System
por: Zhao, Zheng, et al.
Publicado: (2022)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation
por: Chen, Wenlin, et al.
Publicado: (2023)

Quantitative Analysis of the MGMT Methylation Status of Glioblastomas in Light of the 2021 WHO Classification
por: Häni, Levin, et al.
Publicado: (2022)

Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
por: Zhao, Binghao, et al.
Publicado: (2022)

The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors
por: Bale, Tejus A., et al.
Publicado: (2022)

Prognostic Value of Choline and Other Metabolites Measured Using (1)H-Magnetic Resonance Spectroscopy in Gliomas: A Meta-Analysis and Systemic Review
por: Shi, Yixin, et al.
Publicado: (2022)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
por: Wang, Yuekun, et al.
Publicado: (2020)

The 2007 WHO Classification of Tumours of the Central Nervous System
por: Louis, David N., et al.
Publicado: (2007)

The 2007 WHO classification of tumours of the central nervous system
por: Louis, David N., et al.
Publicado: (2007)

Neuroimaging of pediatric tumors of the sellar region—A review in light of the 2021 WHO classification of tumors of the central nervous system
por: Maia, Rúben, et al.
Publicado: (2023)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know—a minireview
por: Torp, Sverre Helge, et al.
Publicado: (2022)

The WHO classification of tumors of the central nervous system‐finally here, and welcome!
por: Rodriguez, Fausto J.
Publicado: (2022)

Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance
por: Stoyanov, George S, et al.
Publicado: (2022)

Multi-Omics Investigations Revealed Underlying Molecular Mechanisms Associated With Tumor Stiffness and Identified Sunitinib as a Potential Therapy for Reducing Stiffness in Pituitary Adenomas
por: Wang, Zihao, et al.
Publicado: (2022)

Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond
por: Kresbach, Catena, et al.
Publicado: (2022)

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
por: KOMORI, Takashi
Publicado: (2017)

A simplified overview of the World Health Organization classification of central nervous system tumors 2021
por: Prajapati, Hanuman Prasad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9t80hjfbg26aael34ruerka67n